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Flu-Related Hospitalizations in Children
Abstract
An estimated 20,000 children are hospitalized each year with influenza-related illnesses. Children with certain
chronic conditions are at higher risk for serious influenza (flu) complications, and recommendations for
annual flu vaccines have been targeted at these children. Over the past four years, public health officials have
expanded their recommendations about which children should be immunized against the flu. This Issue Brief
summarizes clinical outcomes and costs from the largest study to date of children hospitalized with the flu.
These findings should help inform clinicians and policymakers in prioritizing their efforts to implement the
new recommendations.
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Flu vaccine now
recommended for children
ages 6 months to five years
Flu-Related Hospitalizations in Children
Editor’s note: An estimated 20,000 children are hospitalized each year
with influenza-related illnesses. Children with certain chronic conditions
are at higher risk for serious influenza (flu) complications, and
recommendations for annual flu vaccines have been targeted at these
children. Over the past four years, public health officials have expanded
their recommendations about which children should be immunized
against the flu. This Issue Brief summarizes clinical outcomes and costs
from the largest study to date of children hospitalized with the flu. These
findings should help inform clinicians and policymakers in prioritizing
their efforts to implement the new recommendations.
In the United States, influenza outbreaks typically occur during the winter
months, and are responsible for about 36,000 deaths and 200,000
hospitalizations each year.  Influenza-related deaths in children are rare, but
hospitalization rates for children are similar to those for the elderly and for adults
with chronic conditions.  Annual influenza vaccination is the primary way to
prevent infection and its complications.
• Population-based studies suggest that people with certain chronic medical
conditions are at increased risk of serious flu complications.  These conditions
include asthma and other respiratory diseases, cardiac disease,
immunosuppression, chronic kidney disease, and metabolic and endocrine
conditions.
• National guidelines indicate that children with high-risk conditions receive
annual flu vaccines. Last year, this recommendation was extended to all
children 6-23 months of age. This year, the recommendation was extended to
all children ages 6 months to five years.
• Actual vaccination rates lag far behind these recommendations. Estimates
from 2005 suggest 48% vaccination coverage among children aged 6-23
months and 35% coverage among children aged 2-17 years who had one or
more high-risk medical conditions.
Study of hospitalized
children sheds light on flu-
related complications
Neurological/
neuromuscular conditions
and cardiac disease are
risk factors for flu
complications or
prolonged hospital stays
To understand the clinical course and serious complications in children with the
flu, Keren and colleagues studied 745 children 21 years and younger who were
hospitalized for influenza at the Children’s Hospital of Philadelphia in four
consecutive flu seasons (July 2000-June 2004). All patients had acquired the flu
in the community. The diagnosis was confirmed by laboratory tests.
• About 25% were infants less than six months old, a group for
whom neither flu vaccines nor antiviral medications are
currently licensed. About 77% of patients were under age 5.
• More than half of the patients were African-American, in part
reflecting the racial composition of the surrounding
neighborhood (see neighborhood analysis on next page).
• Forty-three percent of patients had at least one chronic
condition recognized as a risk factor for severe flu infection.
The most prevalent appear in the table at left.  The researchers
also analyzed the prevalence of two other conditions suspected
of being risk factors for flu complications at that time:
neurological/neuromuscular disease and gastroesophageal reflux
disease.
• The vaccination status of the patients in the study was not
known.
Of greatest concern to parents and health professionals is the potential for serious
flu-related complications, such as respiratory failure and death. The researchers
analyzed risk factors for these complications and prolonged hospitalizations
(more than six days).
• A total of 132 patients (25%) experienced at least one flu-related
complication.  Pneumonia was most common (15%).
• Thirty-two children (4.3%) had respiratory failure, defined as the need for
mechanical ventilation. Of those patients, five died.
• Adjusting for other factors, patients with neurological/neuromuscular disease,
chronic pulmonary conditions other than asthma, and cardiac disease were at
much higher risk of respiratory failure than other patients. Overall, patients
with any of these conditions had about a 10% chance of respiratory failure.
Having two of the three chronic conditions increased that probability to 31%-
39%.
• The median length of stay was 2 days, but 12% of patients were hospitalized
for more than six days.  Patients with neurological/neuromuscular or cardiac
disease had a much higher likelihood of a prolonged hospitalization than other
patients.
• These results support the decision in 2005 to add neurological/neuromuscular
disease to the list of chronic conditions in children that warrant annual flu
vaccination.
Known high-risk conditions (as of 2004)
Asthma 24%
Immunosuppressive disorder 8%
Cardiac disease 7%
Hemoglobinopathy 6%
Chronic pulmonary disease
(other than asthma) 4%
Metabolic disease 3%
Long-term salicylate therapy 2%
Chronic renal dysfunction 1%
Suspected high-risk conditions
Neurological/neuromuscular disease 12%
Gastroesophageal reflux disease 14%
Chronic medical conditions in children
hospitalized with the flu
Continued on back.
Each flu hospitalization
costs more than $13,000,
much higher than
previously estimated
Neighborhood analysis
estimates the rate of flu
hospitalizations in the
population
Keren and colleagues calculated the direct medical costs of influenza-related
hospitalizations.  From hospital billing records, the average hospital charge was
$26,172 (not including physician services), and the average total reimbursement
for the hospital was $14,770. The researchers used cost-to-charge ratios and
other standards to estimate direct medical costs, including physician services, in
2004 dollars.
• The average cost was $13,159, although costs were much higher for the 19%
of patients admitted to an intensive care unit (ICU).  These more seriously ill
patients had total costs of $39,792, compared with $7,030 for patients cared
for on wards only.
• Room charges accounted for most of the costs in both ward and ICU patients
(75% and 58% respectively).  Diagnostic tests and therapeutic costs (mostly
lab tests and pharmaceuticals) for ICU patients were nearly ten times greater
than for ward patients.
• Children with cardiac, metabolic, and neurologic/neuromuscular disease, and
those 18 to 21 years old, had the greatest likelihood of having high-cost
hospitalizations.
• These cost estimates are three to four times higher than estimates derived from
previous smaller studies.
To estimate the overall incidence of flu-related hospitalization in children, the
researchers defined a neighborhood “cohort” of children living in 9 contiguous
zip codes that surround the hospital. Among the 745 patients, 231 (31%) lived
in the neighborhood.
• Compared to the entire group of children in the study, hospitalized children
from the neighborhood were more likely to be African-American (90% vs.
55%) and more likely to have asthma (31% vs. 24%).  Hospitalized children
from the neighborhood were also more likely to be African American than the
underlying population of children in the neighborhood (90% vs. 77%).
• Using U.S. Census data to calculate the population of children in the
neighborhood, the researchers estimated that the incidence of flu-related
hospitalization was 7-8 per 10,000 child-years of observation. Children 0-23
months of age had the highest rate of flu-related hospitalizations (41.6 per
10,000 child-years).
Influenza is a common cause of hospitalization among both healthy and
chronically ill children. How vaccination status affected the children in this
study, or will affect hospitalization rates in the future, is not known. However,
these findings should help clinicians and policymakers prioritize their
vaccination efforts.
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POLICY IMPLICATIONS
Continued
• Because children with cardiac or neurologic/neuromuscular disease are at risk
of serious complications and prolonged hospitalization from the flu, children
with these conditions and their close contacts should be a high priority to
receive the vaccine.
• The neighborhood analysis supports the public health recommendation to
give priority to children aged 6-23 months for receiving the vaccine because
they are at increased risk for hospitalization compared to children over 24
months of age.
• The cost findings strengthen the economic case for vaccinating children with
high-risk conditions against the flu. In estimating the cost-effectiveness of flu
vaccination, researchers should incorporate these higher inpatient cost
estimates into their analyses.
• Further research is needed to assess the effectiveness, and cost-effectiveness, of
the flu vaccine in preventing hospitalizations and serious complications in
children now recommended for annual vaccination.
